Literature DB >> 1460048

Positive regulation of the skeletal alpha-actin gene by Fos and Jun in cardiac myocytes.

N H Bishopric1, V Jayasena, K A Webster.   

Abstract

Transcription of the skeletal alpha-actin gene is selectively activated in rat myocardiocytes undergoing hypertrophy both in vivo and in vitro. In most of these models, transient expression of certain proto-oncogene transcription factors precedes hypertrophy and sarcomeric gene induction. Using expression vectors encoding Fos and Jun, the main constituents of transcriptional activator protein AP-1, we analyzed the role of these oncoproteins in mediating the transcriptional induction of skeletal alpha-actin by adrenergic stimulation. Both c-fos and c-jun were induced early after beta-adrenergic stimulation, with peak mRNA levels preceding skeletal alpha-actin induction by several hours. A second peak of c-jun mRNA coincided with skeletal alpha-actin induction. Co-transfection assays in cardiac myocytes and P19 teratocarcinoma cells demonstrated that over-expression of c-jun, or c-fos plus c-jun, transactivated the skeletal alpha-actin promoter by about 5-fold. Comparable activation was not seen for alpha-myosin heavy chain or cardiac alpha-actin promoters. Skeletal alpha-actin promoter sequences between -153 and -36 were required for maximal transactivation by c-fos/c-jun, and purified Fos and Jun were bound specifically within this region. A direct physiological role is suggested for the AP-1 transcription factor complex in regulating skeletal alpha-actin gene expression and alpha-actin isoform switching during the onset of signal-mediated cardiac myocyte hypertrophy.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1460048

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  18 in total

1.  AFos dissociates cardiac myocyte hypertrophy and expression of the pathological gene program.

Authors:  Mark Y Jeong; Koichiro Kinugawa; Charles Vinson; Carlin S Long
Journal:  Circulation       Date:  2005-03-28       Impact factor: 29.690

Review 2.  Cellular mechanisms of cardiac hypertrophy.

Authors:  P E Glennon; P H Sugden; P A Poole-Wilson
Journal:  Br Heart J       Date:  1995-06

3.  Reversal of pathological cardiac hypertrophy via the MEF2-coregulator interface.

Authors:  Jianqin Wei; Shaurya Joshi; Svetlana Speransky; Christopher Crowley; Nimanthi Jayathilaka; Xiao Lei; Yongqing Wu; David Gai; Sumit Jain; Michael Hoosien; Yan Gao; Lin Chen; Nanette H Bishopric
Journal:  JCI Insight       Date:  2017-09-07

4.  Nitric oxide synthase inhibitors reduce sarcomere addition in rat skeletal muscle.

Authors:  T J Koh; J G Tidball
Journal:  J Physiol       Date:  1999-08-15       Impact factor: 5.182

5.  Mitogen-activated protein kinase translocates to the nucleus during ischaemia and is activated during reperfusion.

Authors:  Y Mizukami; K i Yoshida
Journal:  Biochem J       Date:  1997-05-01       Impact factor: 3.857

6.  Modulation of MLC-2v gene expression by AP-1: complex regulatory role of Jun in cardiac myocytes.

Authors:  S K Goswami; S Shafiq; M A Siddiqui
Journal:  Mol Cell Biochem       Date:  2001-01       Impact factor: 3.396

7.  Transactivation of mouse insulin-like growth factor II (IGF-II) gene promoters by the AP-1 complex.

Authors:  A Caricasole; A Ward
Journal:  Nucleic Acids Res       Date:  1993-04-25       Impact factor: 16.971

8.  Immediate-early gene induction and MAP kinase activation during recovery from metabolic inhibition in cultured cardiac myocytes.

Authors:  A Yao; T Takahashi; T Aoyagi; K Kinugawa; O Kohmoto; S Sugiura; T Serizawa
Journal:  J Clin Invest       Date:  1995-07       Impact factor: 14.808

9.  Selective translation of mRNAs in the left ventricular myocardium of the mouse in response to acute pressure overload.

Authors:  Laura S Spruill; Catalin F Baicu; Michael R Zile; Paul J McDermott
Journal:  J Mol Cell Cardiol       Date:  2007-10-25       Impact factor: 5.000

10.  Acute hypertension activates mitogen-activated protein kinases in arterial wall.

Authors:  Q Xu; Y Liu; M Gorospe; R Udelsman; N J Holbrook
Journal:  J Clin Invest       Date:  1996-01-15       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.